List of insiders holdings for Terns Pharmaceuticals Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. Vivo Opportunity LLC Vivo Opportunity Fund L.P. 10% Owner | 2024-11-14 19:00:26 | 4,597,243 0 | 4,597,243 | Form 13G |
| 2 | Vivo Opportunity LLC Vivo Opportunity Fund Holdings L.P. Vivo Capital VIII LLC Vivo Capital Fund VIII L.P. Vivo Capital Surplus Fund VIII L.P. 10% Owner | 2024-11-14 19:00:26 | 4,597,243 0 | 4,597,243 | Form 13G |
| 3 | ORBIMED ADVISORS LLC OrbiMed Capital GP VII LLC OrbiMed Asia GP III L.P. OrbiMed Advisors III Ltd OrbiMed Genesis GP LLC Director 10% Owner | 2025-11-05 16:13:10 | 4,240,068 0 | 4,240,068 | Form 13D |
| 4 | LAV Biosciences Fund V L.P. Hopewell Resources Holdings Ltd LAV Aqua Ltd Oriental Spring Venture Ltd 10% Owner | 2024-02-13 17:21:57 | 2,901,566 0 | 2,901,566 | Form 13G |
| 5 | GORDON CARL L Director 10% Owner | 2024-07-17 20:53:02 | 0 755,635 | 755,635 | Form 4 |
| 6 | Zhong Weidong Chief Scientific Officer | 2021-02-04 17:12:41 | 513,520 0 | 513,520 | Form 3 |
| 7 | Jung Melita Sun Chief Business Officer | 2025-02-03 19:28:43 | 327,250 0 | 327,250 | Form 4 |
| 8 | Russell Kerry Strong Chief Medical Officer | 2022-07-06 20:07:09 | 240,000 0 | 240,000 | Form 4 |
| 9 | Strauss David Eric Principal Accounting Officer | 2025-02-11 18:06:38 | 237,173 0 | 237,173 | Form 3 |
| 10 | Quirk Erin President, Head of R&D | 2024-01-25 19:17:02 | 225,000 0 | 225,000 | Form 4 |
| 11 | Yoon Seokho Bryan COO and General Counsel | 2024-06-04 18:06:20 | 91,940 0 | 91,940 | Form 4 |
| 12 | Vignola Mark J. Chief Financial Officer | 2025-01-06 19:30:43 | 74,752 0 | 74,752 | Form 4 |
| 13 | Lu Hongbo Director | 2025-06-12 17:44:19 | 45,000 0 | 45,000 | Form 4 |
| 14 | Sundaram Senthil Vel Chief Executive Officer | 2023-06-02 17:03:03 | 9,770 0 | 9,770 | Form 4 |
| 15 | Taylor Ann Elizabeth Director | 2024-07-02 18:37:36 | 4,676 0 | 4,676 | Form 4 |
| 16 | Flynn James E DEERFIELD MANAGEMENT COMPANY L.P. (SERIES C) DEERFIELD PARTNERS L.P. Deerfield Mgmt L.P. Possible Member of 10% Group 10% Owner | 2023-10-04 17:09:36 | 0 0 | 0 | Form 13G |
| 17 | Burroughs Amy L. Chief Executive Officer | 2026-05-05 17:00:12 | 0 0 | 0 | Form 4 |
| 18 | Gengos Andrew Chief Financial Officer | 2026-05-05 17:01:10 | 0 0 | 0 | Form 4 |
| 19 | Kuriakose Emil Chief Medical Officer | 2026-05-05 17:02:07 | 0 0 | 0 | Form 4 |
| 20 | FELLOWS DAVID A Director | 2026-05-05 17:03:09 | 0 0 | 0 | Form 4 |
| 21 | KINDLER JEFFREY B Director | 2026-05-05 17:04:08 | 0 0 | 0 | Form 4 |
| 22 | Quigley Jill M. Director | 2026-05-05 17:05:05 | 0 0 | 0 | Form 4 |
| 23 | Tripuraneni Radhika Director | 2026-05-05 17:06:03 | 0 0 | 0 | Form 4 |
| 24 | Turner Heather D Director | 2026-05-05 17:07:07 | 0 0 | 0 | Form 4 |
| 25 | Azelby Robert Director | 2026-05-05 17:08:07 | 0 0 | 0 | Form 4 |